Unlocking Nutraceutical Potential: Metabolomic Analysis Reveals Therapeutic Compounds in Rice
- 1*,
- 2,
- 3,
- 4,
- 4,
- 5,
- 5
- 1Department of Plant Breeding and Genetics, Regional Agricultural Research Station, Pattambi, Kerala, INDIA.
- 2Department of Agricultural Entomology, College of Agriculture, Vellanikkara, Kerala, INDIA.
- 3Department of Grain Science Technology, Central Food Technology Research Institute, Mysuru, Karnataka, INDIA.
- 4Department of Plant Breeding and Genetics, College of Agriculture, Vellanikkara, Kerala, INDIA.
- 5Department of Plant Biotechnology and Molecular Biology, College of Agriculture, Vellanikkara, Kerala, INDIA.
Published in Journal of Pharmacology and Pharmacotherapeutics
Correspondence: Konganam Veedu Faseela
Department of Plant Breeding and Genetics, Regional Agricultural Research Station, Pattambi, Kerala, INDIA.
Email: faseela.kv@kau.in
Copyright: © 2025 The Author(s). This is an open access article.
Published: Jan 1, 2025, Received: Aug 22, 2024, Accepted: Nov 29, 2024
Abstract
Background: Rice varieties enriched with potential bioactive compounds are poised to make a significant contribution to global health. It is anticipated that edible medications made from rice seeds will lead to novel therapeutics. Objectives: High-yielding popular pigmented and nonpigmented rice varieties were selected for in-depth analysis of bioactive contents. Nutraceutical potential of high-yielding rice varieties often goes underexplored compared to low-yielding specialty rice varieties. This study addresses the gap by metabolomic profiling of popular rice varieties to uncover bioactive compounds with significant pharmaceutical and nutritional benefits. Materials and Methods: Untargeted metabolomic profiling of the brown rice of pigmented and nonpigmented varieties was conducted by Orbitrap-high-resolution liquid chromatography and mass spectrometry, and primary and secondary metabolites were identified and annotated. 2,2-Diphenyl-1-picrylhydrazyl (DPPH) free radical scavenging (RS) assay was carried out to identify the variety with superior antioxidant activity. Correlation analysis by using Metaboanalyst software identified major metabolites with RS potential. Over-representation analysis was performed for the Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway enrichment, and major pathways were identified for metabolites with nutraceutical potential in pigmented rice. Results: Major metabolites with antioxidant, anti-inflammatory, and anticarcinogenic properties were identified from rice varieties. Bioactive compounds detected from brown rice included choline, didodecyl-3,3-thiodipropionate, conjugated linoleic acid, oleic acid, 13(S)-HOTrE, monoolein, nicotinic acid, pantothenic acid, isoquinoline, trigonelline, corymboside, ferulic acid, and 2,4-quinolinediol. The DPPH RS assay revealed superior antioxidant activity in the pigmented rice, with differential metabolites from the pathways of phenylpropanoid biosynthesis, arginine and proline metabolism, and biosynthesis of unsaturated fatty acids showing a significant correlation (p < .01) with RS potential. Conclusion: Catechin, (–)-epicatechin, (±)12(13)-DiHOME, 4-guanidinobutyric acid, and 5-methoxysalicylic acid are key metabolites that emphasize the antioxidant potential of red-colored rice as a functional food with significant health benefits. The study highlights the therapeutic promise of pigmented whole-grain rice.
Keywords
Subject
Recommended articles
- A Review on Pharmacological Advancement of Ellagic Acid
Pougang Golmei, Sweta Kasna, Kumar Probin Roy · Journal of Pharmacology and Pharmacotherapeutics
Readers Also Viewed
Pharmacogenomics Meets Generative AI: Transforming Clinical Trial Design with Large Language Models
Annisa Fatharani, Ali Alsayegh
Jan 1, 2026
Clinical Outcomes and Management of Post-varicocelectomy on Male Fertility: A Comprehensive Review
Mohammad Akbar Hossain
Jan 1, 2026
Knowledge, Attitude, and Practice on Digital Eye Strain Among Healthcare Students at a Private University in Northern Peninsular Malaysia
Lim Chin Hung, Subramani Parasuraman, Sam Aaseer Thamby
Jan 1, 2026